DC Discusses LIVE: DC FEST US 2025

Asia Access Connect: A new era for Japanese M&A 

DC Advisory was joined by Hirohisa Akahira, Director at Japan External Trade Organization, and Ryo Okubo and Mayuko Tsujimoto, Partners at Nagashima Ohno & Tsunematsu NY LLP for an Asia Access Connect session hosted in Japanese.

Senior colleagues from Daiwa Securities and DC Advisory participated, including Toru Yamamoto (Head of Global Investment Banking) and Koki Kaita (Senior Managing Director) from Daiwa Securities, as well as Tosh Kojima (Managing Director), Satoshi Ishiguro (Executive Director), and Kenta Nakagawa (Director) from DC Advisory.

Together, the panel explored the evolving Japanese M&A landscape, including:

• The rise in cross-border activity and its implications for deal structuring
• Shifting corporate strategies in response to changing market dynamics
• The growing importance of regulatory insight in navigating Japan’s M&A environment
• Market perspectives from both Daiwa Securities and DC Advisory on investor sentiment and deal momentum

Asia Access Connect: A new era for Japanese M&A (in Japanese)

Watch the video

DC Discusses LIVE: Navigating 2025 market dynamics, Chemicals & Materials M&A trends and outlook

DC Advisory Managing Director  Federico Mennella, CFA, and Director, Domenico Fortuna, were joined by Sylvestre Pires, Managing Partner at Advancy and Vincent Valk, Senior Editor of Chemical Week by S&P Global on a panel to discuss the current state and outlook of the Chemicals & Materials industry, delving into topics including:

• Potential impact of global tariffs across the Chemicals value chain
• Navigating uncertainty in today’s market environment
• China: strategic and economic considerations
• Demand outlook and expectations for 2025/2026 and beyond
• Investment and M&A activity – current trends and future catalysts
• Strategies to identify opportunities and position for future success

DC Discusses LIVE: Navigating 2025 market dynamics, Chemicals & Materials M&A trends and outlook

Watch the video

DC Discusses LIVE: An evolving paradigm, US Executive Branch's impact on Healthcare M&A

DC Advisory’s Healthcare Managing Directors Manish Gupta, Hector Torres, and Director, Aaron Newman hosted a panel to discuss: ‘An Evolving Paradigm: Executive Branch Impact on Healthcare M&A.’ They were joined by Brian Fortune, President at Farragut Square Group, and Ken Marlow, Partner at McDermott Will & Emery, where they discussed:

• The broad-based healthcare M&A landscape remains challenging, stagnant, yet cautiously optimistic, with optimal preparation, planning and “pre-market” diligence becoming more essential than ever
• Present market conditions require both creativity and flexibility, with specific deal terms and conditions serving as the foundation for the underwriting of both regulatory and financial profile-related risks
• Despite the tariff, anti-trust, regulatory and DOGE-related headlines coming from Capitol Hill, highest quality companies across the healthcare sector are commanding strong market interest at attractive terms

DC Discusses LIVE: An evolving paradigm, US Executive Branch impact on Healthcare M&A

Watch the video

DC Advisory has prepared this material solely for informational purposes and it is not a research report. This material does not constitute or form part of, and should not be construed as, an offer to sell, or a solicitation of any offer to buy, or any recommendation with respect to, any securities. For other important information, please read our Insights & Publications disclaimer >

*For important information about these presentations, read our full disclaimer > 

What to read next

insight

DC Discusses LIVE: DC FEST UK 2025

July 8, 2025

Deal Announcement

DC Advisory advises Laxton on its majority investment from DNP

June 18, 2025